Skip to main content

Table 1 Demographics, site of disease, strain family and drug resistance profile in new patients with culture–confirmed tuberculosis diagnosed in New South Wales, Australia

From: Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia

Category Year Total
2010 2011 2012 n (%)
Gender     
   Male 219 (61.3) 219 (59.0) 188 (53.6) 626 (58.0)
Age group     
   <15 years 4 (1.1) 5 (1.3) 6 (1.7) 15 (1.4)
   15-29 years 99 (27.7) 94 (25.3) 102 (29.1) 295 (27.3)
   30-44 years 110 (30.8) 116 (31.3) 102 (29.1) 328 (30.4)
   45-59 years 63 (17.6) 60 (16.2) 48 (13.7) 171 (15.8)
   ≥60 years 81 (22.7) 96 (25.9) 93 (26.5) 270 (25.0)
Site of disease     
   Respiratory 258 (72.3) 260 (70.1) 241 (68.7) 759 (70.3)
   Non-respiratory 99 (27.7) 111 (29.9) 110 (31.3) 320 (29.7)
Strain family     
   Beijing 93 (26.1) 108 (29.1) 97 (27.6) 298 (27.6)
   East African Indian 112 (31.4) 101 (27.2) 95 (27.1) 308 (28.5)
   Delhi/CAS 47 (13.2) 53 (14.3) 49 (14.0) 149 (13.8)
   LAM 25 (7.0) 14 (3.8) 22 (6.3) 61 (5.7)
   Haarlem 13 (3.6) 21 (5.7) 24 (6.8) 58 (5.4)
   Other 67 (18.8) 74 (19.9) 64 (18.2) 205 (19.0)
Drug resistance     
   Isoniazid mono-resistance 21 (5.9) 23 (6.2) 29 (8.3) 73 (6.8)
   Multi- or extremely drug resistant (M/XDR) 7 (2.0) 6 (1.6) 5 (1.4) 18 (1.7)
Total 357 (100) 371 (100) 351 (100) 1079 (100)